Following you will find information from the original Educate the Educators program. While some of this information is now out-of-date, we wanted to share with you as a reference. We look forward to providing you with new information in the Educate the Educators II program.
Each year brings important updates to how women in the
United States should be screened with HPV testing. The importance of
testing for high risk HPV types in specific clinical
scenarios have been well established and recent data
have demonstrated the importance of identification of specific HPV
types. The FDA has approved a HPV 16 and 18
genotyping test, and in order to assist clinicians with
national utilization of this new test, the ASCCP has put forth a guideline with an algorithm, as well as additional educational information on how
to appropriately use this test in women 30 years of age or older.
Educate the Educators: HPV and the HPV Vaccines Program (Non-CME)
The ASCCP has expanded our Educate the Educators program by initiating a series of periodic updates. This has included PDFs of the articles, as well as a commentary prepared by the Educate the Educators editorial committee. The commentary not only provides a synopsis of the key findings, but also attempts to put them into context. We are also making available for download PowerPoint slides documenting what we believe to be the key message from these articles. From time to time, there will also be news items of general interest to our readership and we will cover these in a "What's New?" section of the Literature Update. The 2009-2011 Educators Editorial Committee is composed of Mark H. Einstein, MD, Michael A. Gold, MD, Kenneth L. Noller, MD, Katherine E. Sharpless, MD, Kate M. Stampler, DO, Colleeen Stockdale, MD, Jeffrey Waldman, MD, and Thomas C. Wright, MD.
What is the Educate the Educators' program? In 2005,
ASCCP realized that the implementation and rational use of the then new
prophylactic HPV vaccines would require the diffusion
of expertise in HPV biology throughout the U.S. medical
community-with the greatest challenge being in the smaller and mid-sized
communities that lack clinicians who have expertise
in this area. To help meet that need, ASCCP developed
the Educate the Educators' Program, a two armed program featuring a
series of non-CME training courses and CME home study assessment
programs designed to train ASCCP members and other
providers to become local community experts and 'second generation
trainers' for Local Education Programs (LEP). The initial non-CME
formal training and webinairs are no longer offered.
Note: The non-CME 2009-2010 Educate the
Educators' Updates were produced specifically through grants received in
2008-09 from Merck & Company, Hologic, Qiagen, mtm laboratories,
and Roche. Lectures in this Series were developed and produced
free of commercial support.
2012 Consensus Conference on the Management of Abnormal Cervical Cancer Screening Tests and the Management of CIN/AIS
On September 14 and 15, 2012, the ASCCP worked with 23 other national organizations on a revision of the 2006 guidelines for management of abnormal screening tests and CIN/AIS. Most of the 2006 guidelines will remain unchanged, but areas of review include management of discordant HPV/Pap co-tests, definition of routine screening after initial assessment, and expansion of the adolescent management guidelines to include women up to age 25. We also are reviewing ASCCP's guidelines on managing women with unsatisfactory Paps or Paps with absent/insufficient endocervical cells or transformation zone component.
The draft recommendations to the Update to the 2006 ASCCP Consensus Conference on the Management of Cytological Abnormalities and Cervical Cancer Precursors was open for public comment during the month of August and the Work Groups finalized the draft recommendations. These recommendations were presented, discussed, and voted upon at the September 2012 conference. The Steering Committee is now preparing the updated guidelines based on the recommendations from the conference. The final guidelines will be published in the Journal of Lower Genital Tract Disease.